載入中… Loading…
載入中… Loading…
On 11-13 the Biotechnology and medical care sector index closed at 93.32: +6.47% over 1 week, +3.20% over 1 month, -8.99% over 3 months and +19.40% over 1 year. Combined monthly revenue for 2026/10 was +10.8% year on year (153 companies). The median P/E is 15.0, at the 4th percentile of the last 5 years.
| Month | Combined YoY | Companies |
|---|---|---|
| 2026/10 | +10.8% | 153 |
| 2026/09 | +20.8% | 155 |
| 2026/08 | +21.5% | 155 |
| 2026/07 |
Median P/E
15.0
4th percentile of the last 5 years
Median P/B
1.83
4th percentile of the last 5 years
Data date 2026-11-13, 160 stocks. The percentile compares with this sector's own history; it does not mean expensive or cheap.
It is TWSE's "生技醫療類指數", tracking the overall share-price movement of listed companies in the industry as a price index, without dividend reinvestment. 160 listed and OTC common stocks belong to this industry classification.
For companies in the industry that reported the month and had revenue in the same month last year, this month's combined revenue divided by last year's combined revenue minus 1. It shows the industry's operating momentum; companies report at different times, so early in the month fewer companies are included, and the number is shown.
We take the median P/E of companies in the industry (positive values only) and compare it with the industry's median at each period over the last 5 years, showing the share of history that is at or below today. It is a relative position versus its own history, not a statement of cheap or expensive and not advice.
All sectorsMarket breadthScreenerHow to read sector indexes and rotation
Data date 2026-11-13Source: TWSE industry sector price indexes, daily trading and valuation data, and MOPS monthly revenue. For education and personal reference only; not investment advice.
| +13.3% |
| 155 |
| 2026/06 | +20.4% | 153 |
| 2026/05 | +13.5% | 156 |
| 2026/04 | +5.9% | 155 |
| 2026/03 | +15.9% | 152 |
| 2026/02 | +2.6% | 153 |
| 2026/01 | +8.9% | 152 |
| 2025/12 | +3.1% | 153 |
| 2025/11 | +2.8% | 154 |
| 6861 睿生光電 |
| 193.5 |
| +7.50% |
| 1.96 |
| 6617 共信-KY | 137 | +7.03% | 1.77 |
| 6782 視陽 | 285 | +2.15% | 1.26 |
| 6589 台康生技 | 55.6 | +2.96% | 1.22 |
| 4147 中裕 | 64.3 | +3.71% | 0.91 |
| 6547 高端疫苗 | 46.85 | +0.11% | 0.87 |
| 4105 東洋 | 84.1 | +0.48% | 0.76 |
| 6491 晶碩 | 392.5 | +1.82% | 0.63 |
| 6535 順藥 | 85.1 | +9.95% | 0.56 |
| 4128 中天 | 14.5 | +9.43% | 0.44 |
| 4114 健喬 | 27.45 | -0.36% | 0.35 |
| 1786 科妍 | 50.6 | +3.05% | 0.34 |
| 1565 精華 | 85 | +1.07% | 0.32 |
| 6469 大樹 | 60.9 | +7.22% | 0.29 |
| 4123 晟德 | 28.9 | +2.12% | 0.28 |
| 4746 台耀 | 46.7 | +2.08% | 0.28 |
| 4155 訊映 | 17.35 | +3.89% | 0.25 |
| 4747 強生* | 15.75 | +9.76% | 0.25 |
| 8436 大江 | 92.3 | +1.88% | 0.24 |
| 6945 圓祥生技 | 118 | +3.51% | 0.24 |
| 4169 泰宗 | 121.5 | +0.41% | 0.23 |